Sorin collects EU approval for its Intensia family of cardiac devices

Intensia ICD and CRT-D implant--Courtesy of Sorin

Notching another CE mark in its cardiac cache, Italian devicemaker Sorin nabbed European approval for its Intensia family of implantable cardiac defibrillator and cardiac resynchronization therapy (CRT) devices. The batch of devices includes both a single-chamber and a dual-chamber implant, as well as one with Sorin's self-adjusting SonR algorithm, which has shown in the clinic to improve CRT response by 23%. And all of the Intensia devices use the DF-4 high-voltage connector, which requires only one connection as opposed to two or three and has become an industry standard. Sorin is expecting big growth next year with its focus on new products, and just last month the company picked up another CE mark for its stentless aortic valve replacement Freedom Solo Smart. Release

Suggested Articles

J.D. Power aims to set the benchmarks in telehealth satisfaction with a new study due this November.

Atomwise plans to screen up to 10 billion virtual compounds for therapies against childhood cancer in collaboration with chemical supplier Enamine.

The Chan Zuckerberg Initiative set aside $68 million for over three dozen projects in an effort to map out every type of cell in the body.